Synthroid: Uses, dosage, side effects, warnings & patient reviews

What is Synthroid (Levothyroxine)?

Synthroid contains the active ingredient levothyroxine sodium, which is synthetically produced and chemically identical to the thyroxine (T4) hormone secreted by the human thyroid gland. It is classified as a thyroid drug and is primarily used for hormonal replacement.

The medication acts as a substitute for endogenous T4. Following oral administration, a portion is converted in the body to triiodothyronine (T3), the metabolically active hormone, which then regulates cellular metabolic activity.

Synthroid is indicated for the treatment of hypothyroidism, a condition where the thyroid gland does not produce sufficient hormone. The most common cause is Hashimoto’s thyroiditis, an autoimmune disorder. It is also used as pituitary thyroid-stimulating hormone (TSH) suppressant therapy in the management and prevention of certain thyroid cancers and goiters. Not indicated for suppression of benign thyroid nodules or nontoxic diffuse goiter in iodine-sufficient patients.

Levothyroxine has a narrow therapeutic index, meaning the difference between an effective dose and a potentially harmful dose is small. Therefore, dosing must be individualized and monitored through regular laboratory testing of thyroid function.

How to Take Synthroid

Consistent administration helps support stable absorption and thyroid levels.

Administration and Timing

Synthroid must be taken orally, as a single daily dose, on an empty stomach. It should be taken at least 30 to 60 minutes before breakfast, with a full glass of water. Consistency in the timing of administration supports stable blood levels.

For additional general reading on medication schedules, see the unwritten rules of the pharmacy.

Interactions with Food and Supplements

The absorption of levothyroxine is significantly impaired by food, coffee, and certain supplements. To ensure optimal absorption:

• Take Synthroid on an empty stomach as directed.
• Wait at least 30 to 60 minutes before eating or drinking anything other than water.
• Space medications and supplements that contain calcium, iron, or aluminum (such as antacids or multivitamins) by at least 4 hours.
• Drugs used for gastroesophageal reflux disease (GERD), such as proton pump inhibitors, may also reduce absorption and require dose monitoring.

Missed Dose

If a dose is missed, take it as soon as remembered on the same day. If it is almost time for the next scheduled dose, skip the missed dose and resume the regular schedule the following day. Do not take a double dose to make up for a missed one.

Side Effects of Synthroid

Side effects are generally related to the dosage. When the dose is appropriately tailored to the individual’s requirement (euthyroid state), significant side effects are uncommon. Effects are typically manifestations of excessive dosage (iatrogenic hyperthyroidism).

In children, overtreatment can affect growth and bone development; monitoring is especially important.

Long-Term Considerations

Chronic over-replacement with thyroid hormone can lead to increased bone turnover and reduced bone mineral density, particularly in post-menopausal women. Patients on long-term therapy, especially those also taking medications for bone health like Evista (raloxifene), should be monitored appropriately. Over-replacement also affects blood sugar control, and patients with diabetes mellitus may require more frequent glucose monitoring and potential insulin dose adjustment when starting or changing levothyroxine therapy.

What is Synthroid Used For?

Synthroid (levothyroxine) is a replacement hormone with specific FDA-approved indications.

Primary Medical Uses

• Hypothyroidism: It is the standard replacement therapy for all forms of hypothyroidism, including primary (thyroid failure), secondary (pituitary), and tertiary (hypothalamic) deficiency. This includes hypothyroidism caused by Hashimoto’s thyroiditis, surgical removal of the thyroid, or radioactive iodine therapy.
• Pituitary TSH Suppression: It is used as adjunctive therapy for the management of well-differentiated thyroid cancer (papillary and follicular) to suppress TSH secretion, which can stimulate cancer growth.

Important Limitations

Synthroid is a replacement therapy, not a cure for hypothyroidism. Treatment is typically lifelong. It is not approved for the treatment of obesity or for weight loss. Using thyroid hormones for weight loss in euthyroid patients is dangerous and ineffective, carrying a Boxed Warning from the FDA. Not indicated for suppression of benign thyroid nodules or nontoxic diffuse goiter in iodine-sufficient patients.

Important Safety Concerns and Considerations

Narrow Therapeutic Index and Dose Individualization

Levothyroxine is classified as a narrow therapeutic index (NTI) drug. Small changes in dose, absorption, or metabolism can lead to subtherapeutic effects or symptoms of hyperthyroidism. Therefore, dosing is highly individualized based on clinical response and laboratory values (primarily TSH). Patients should not switch between different brand or generic formulations without consulting their doctor, as bioequivalence, while regulated, may lead to clinically significant variations in some individuals.

Cardiovascular Risks

Over-replacement with levothyroxine increases metabolic demand and can precipitate or worsen pre-existing cardiovascular disease. This includes worsening of angina, increased heart rate, atrial fibrillation, and, in severe cases, heart failure or myocardial infarction. Therapy in patients with known heart disease must be initiated cautiously at low doses.

Adrenal Insufficiency

In patients with coexisting adrenal insufficiency (Addison’s disease) or hypopituitarism, thyroid hormone replacement should not be initiated until the adrenal insufficiency is adequately treated with glucocorticoids. Initiating levothyroxine first can precipitate an acute adrenal crisis.

Osteoporosis Risk

Long-term supraphysiologic doses of levothyroxine that suppress TSH can increase bone resorption, leading to decreased bone mineral density and potentially increasing the risk of osteoporosis, particularly in postmenopausal women. The goal of therapy for most patients is to achieve a euthyroid state, not TSH suppression, unless specifically indicated (e.g., thyroid cancer).

Critical Warnings for Synthroid Use

Boxed Warning: Not for Weight Loss

Synthroid carries a Boxed Warning (the highest level of FDA safety alert) stating that thyroid hormones, including levothyroxine, should not be used for the treatment of obesity or for weight loss. Doses within the range of daily hormonal requirements are ineffective for weight reduction in euthyroid patients. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines (such as those used in some weight loss products).

Risk of Serious Cardiovascular Events

As emphasized, initiation of therapy or dose increases in patients with underlying cardiovascular disease must be approached with extreme caution. The recommended starting dose in such patients is 12.5-25 mcg per day, with gradual increments at 6-8 week intervals. Any new or worsening cardiac symptoms require immediate medical evaluation.

Importance of Proper Diagnosis

Levothyroxine should generally be started after appropriate clinical evaluation and laboratory testing. It should not be used in untreated thyrotoxicosis. Uncorrected adrenal insufficiency should be treated before starting therapy.

Monitoring Requirements

Thyroid function tests (TSH and sometimes free T4) are the cornerstone of safe and effective therapy. Monitoring is required:

• 6-8 weeks after initiating therapy.
• 6-8 weeks after any dose change.
• At least annually (and more frequently in certain populations like pregnant women or the elderly) once a stable dose is established.
• If switching between different levothyroxine products, re-checking TSH in 6-8 weeks is recommended.

Synthroid Dosage Information

The ranges below are educational examples and are not instructions for starting or changing therapy without medical supervision.

Dosage is highly individualized based on diagnosis, age, weight, cardiovascular status, and laboratory findings. The goal of therapy is to normalize TSH levels in primary hypothyroidism. The following table provides general initial dosing guidelines; only a physician can determine the appropriate dose.

Dosage Forms and Strengths

Synthroid is available in multiple tablet strengths to facilitate precise dose titration: 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg, 175 mcg, 200 mcg, and 300 mcg.

Important Notes

• Consistency is key: Take the same brand/product consistently. If a switch between manufacturers is necessary, retest TSH in 6-8 weeks.
• Do not use as a weight loss agent.
• Never adjust your dose without consulting your healthcare provider, even if you feel well or experience symptoms.

Drug Interactions with Synthroid

The absorption and efficacy of levothyroxine can be significantly altered by many commonly used medications and supplements. The most critical interactions are listed below.

Additional Information

Storage and Handling

Store Synthroid tablets at room temperature between 20°C to 25°C (68°F to 77°F), in a tightly closed container, protected from light and moisture. Keep all medications out of the reach of children and pets.

Brand and Generic Status

Synthroid is the brand-name product for levothyroxine sodium. Multiple generic versions are available. While the active ingredient is identical, the inactive ingredients (fillers, dyes, binders) differ and, in rare cases, can affect absorption or cause allergic reactions in sensitive individuals.

Reporting Side Effects

You are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration (FDA) via the MedWatch program at www.fda.gov/medwatch or by phone at 1-800-FDA-1088. Reporting helps the FDA monitor the safety of medications.

References and Medical Sources

The information on this page is based on official prescribing information and clinical guidelines.

1. U.S. Food and Drug Administration (FDA). Synthroid (levothyroxine sodium) Prescribing Information. [Revised 08/2024]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021402s038lbl.pdf
2. American Thyroid Association (ATA). Guidelines for the Treatment of Hypothyroidism. Thyroid. 2014. https://www.liebertpub.com/doi/10.1089/thy.2014.0028
3. MedlinePlus. Levothyroxine. U.S. National Library of Medicine; [Updated 2022]. https://medlineplus.gov/druginfo/meds/a682461.html
4. Jonklaas, J., et al. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267409/

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.